Featured / News

Recent News on the Federal Circuit

Here is a report on recent news and commentary related to the Federal Circuit and its cases. Today we highlight:

  • a blog post arguing the Federal Circuit’s application of the judicial exceptions to patentability for software patents “has resembled less a coherent legal standard and more a series of freely-improvised opinions”;
  • an article discussing a recent Federal Circuit decision holding that “composition of matter claims covering engineered cells containing DNA from two different organisms chemically spliced together are not patent-ineligible natural phenomena”;
  • a blog post addressing how the repeal of 35 U.S.C. § 102(f) “left an open question that the patent bar has been debating for more than a decade: can incorrect inventorship still be raised as a defense in patent litigation?”; and
  • a blog post exploring a recent Federal Circuit decision in which the court “couldn’t determine whether the plaintiff suffered a physical taking of its radio license” because the parties had not adequately briefed whether a federal statute created “a private property right.”
Read More
Featured / Panel Activity

Update on Important Panel Activity

Here is an update on activity in cases pending before panels of the Federal Circuit where the cases have attracted at least one amicus brief. We keep track of these cases in the “Other Cases” section of our blog. Today, with respect to these cases, we highlight seven recent opinions, one recent order, and two newly-identified cases. Here are the details.

Read More
Opinions

Opinions & Orders – February 20, 2026

This morning, the Federal Circuit released one precedential opinion and three nonprecedential opinions. The precedential opinion comes in a patent infringement case and reverses a finding of patent ineligibility. Two of the three nonprecedential opinions come in appeals of decisions of the Patent Trial and Appeal Board, while the third nonprecedential opinion comes in an appeal of a decision of the Court of Federal Claims in a vaccine case. Here are the introductions to the opinions.

Read More